In conclusion, the results of the present study provide the first scientific evidence that hepatic and serum levels of BMP8A are abnormally elevated in experimental models of liver fibrosis and in the serum of NASH patients with advanced hepatic fibrosis, indicating that BMP8A is a new molecular target linked to liver fibrogenesis. This evidence concerns the gene BMP8A and Hepatic fibrosis.